Transforming Medicine Through Smart Devices

Hyperfine, Inc., Creator of the First FDA-Cleared Portable MRI Device, and Liminal Sciences, Inc. To Be Listed on Nasdaq Through a Business Combination With HealthCor Catalio Acquisition Corp. ($HCAQ).

The business combination will develop solutions across the care continuum by bringing together Hyperfine and Liminal, two companies with the potential to drive a transformative shift in MR imaging, brain-sensing capabilities, and robotic guided intervention.

Quantum-Si (Ticker: QSi) goes public and starts trading on the NASDAQ.

This will accelerate the development of an open proteomics platform to democratize single molecule analysis — empowering innovators and transforming the future of healthcare through better diagnostics to improve the efficacy of drug treatments

Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp. ($CAPA).

The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP.

Butterfly Network goes public and starts trading on the NYSE.

This will fuel further adoption and help accelerate Butterfly’s current and future pipeline of innovative technologies, which have the potential to transform health care delivery and drive a direct impact for patients.

Butterfly Network announces SPAC merger with Longview Acquisition Corp. ($LGVW).

The merger will accelerate the commercialization of Butterfly’s innovative handheld ultrasound, the Butterfly iQ. NYSE Ticker will officially become “BFLY” in Q1 2021

Hyperfine introduces the world’s first point-of-care MRI which is more affordable, easier to use, and more energy efficient than current machines.

Butterfly iQ is bringing medical imaging to remote communities for the first time.

The New York Times describes how the Butterfly iQ is used in African villages like Bushoro, Uganda.

Jonathan Rothberg Receives the National Medal of Technology & Innovation

President Obama has named Dr. Jonathan Rothberg, founder of medical device incubator 4Catalyzer, as a recipient of the National Medal of Technology and Innovation. The award is the nation’s highest honor for technical achievement and innovation.

Butterfly Network Named in Top 12 Companies Leading the Way in Digital Health and Co-founder Named in Forbes 30 Under 30

Nevada Sanchez, a co-founder at Butterfly Network (a 4Catalyzer company), has been honored as one of Forbes 30 under 30 for 2015.

Butterfly Network Announces Over $100M in Financing to Bring Together Novel Devices, Deep Learning, and Cloud Computing to Transform Medicine

The first of three new healthcare companies from 4Catalyzer that are transforming medical imaging, pharmaceutical development, and diagnostics.